These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 37614952

  • 21. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH, Adams-Huet B, Poindexter JR, Maalouf NM.
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [Abstract] [Full Text] [Related]

  • 22. Low bone mineral density in COPD patients with osteoporosis is related to low daily physical activity and high COPD assessment test scores.
    Liu WT, Kuo HP, Liao TH, Chiang LL, Chen LF, Hsu MF, Chuang HC, Lee KY, Huang CD, Ho SC.
    Int J Chron Obstruct Pulmon Dis; 2015 May; 10():1737-44. PubMed ID: 26366066
    [Abstract] [Full Text] [Related]

  • 23. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [Abstract] [Full Text] [Related]

  • 24. Effect of alendronate treatment on bone mineral density in male patients with osteoporosis.
    Drake AJ, Brietzke SA, Aprill BS, Shakir KM.
    Endocr Pract; 1999 Nov; 5(4):184-90. PubMed ID: 15251673
    [Abstract] [Full Text] [Related]

  • 25. Bone mineral density among elderly patients with chronic obstructive pulmonary disease patients in India.
    Hattiholi J, Gaude GS.
    Niger Med J; 2013 Sep; 54(5):295-301. PubMed ID: 24403704
    [Abstract] [Full Text] [Related]

  • 26. Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis.
    Guaraldi G, Orlando G, Madeddu G, Vescini F, Ventura P, Campostrini S, Mura MS, Parise N, Caudarella R, Esposito R.
    HIV Clin Trials; 2004 Sep; 5(5):269-77. PubMed ID: 15562367
    [Abstract] [Full Text] [Related]

  • 27. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
    Jiang Y, Li M, Xia W, Xing X, Yu W, Tian J, Meng X, Zhou X.
    Zhonghua Yi Xue Za Zhi; 2002 Sep 25; 82(18):1254-6. PubMed ID: 12425805
    [Abstract] [Full Text] [Related]

  • 28. [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
    Yang LJ, Shen FX, Zheng JC, Zhang HL.
    Zhongguo Gu Shang; 2012 Feb 25; 25(2):133-7. PubMed ID: 22577718
    [Abstract] [Full Text] [Related]

  • 29. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
    Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B.
    Chest; 2009 Dec 25; 136(6):1456-1465. PubMed ID: 19581353
    [Abstract] [Full Text] [Related]

  • 30. Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy.
    Cortet B, Béra-Louville A, Gauthier P, Gauthier A, Marchandise X, Delcambre B.
    Joint Bone Spine; 2001 Oct 25; 68(5):410-5. PubMed ID: 11707007
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of osteoporosis and osteopenia diagnosed using quantitative CT in 296 consecutive lumbar fusion patients.
    Carlson BB, Salzmann SN, Shirahata T, Ortiz Miller C, Carrino JA, Yang J, Reisener MJ, Sama AA, Cammisa FP, Girardi FP, Hughes AP.
    Neurosurg Focus; 2020 Aug 25; 49(2):E5. PubMed ID: 32738803
    [Abstract] [Full Text] [Related]

  • 32. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma.
    Katsura H, Kida K.
    Chest; 2002 Dec 25; 122(6):1949-55. PubMed ID: 12475832
    [Abstract] [Full Text] [Related]

  • 33. Preoperative MRI-based vertebral bone quality (VBQ) score assessment in patients undergoing lumbar spinal fusion.
    Salzmann SN, Okano I, Jones C, Zhu J, Lu S, Onyekwere I, Balaji V, Reisener MJ, Chiapparelli E, Shue J, Carrino JA, Girardi FP, Cammisa FP, Sama AA, Hughes AP.
    Spine J; 2022 Aug 25; 22(8):1301-1308. PubMed ID: 35342015
    [Abstract] [Full Text] [Related]

  • 34. COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids.
    Ozcakir S, Sigirli D, Ursavas A, Uzaslan E.
    Int J Chron Obstruct Pulmon Dis; 2020 Aug 25; 15():2441-2448. PubMed ID: 33116459
    [Abstract] [Full Text] [Related]

  • 35. Osteoporosis in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.
    Oh JY, Lee YS, Min KH, Lee SY, Shim JJ, Kang KH, Hur GY.
    Tuberc Respir Dis (Seoul); 2018 Jan 25; 81(1):73-79. PubMed ID: 29256216
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA, Nair V.
    Arch Osteoporos; 2012 Jan 25; 7():147-53. PubMed ID: 23225292
    [Abstract] [Full Text] [Related]

  • 37. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J, Trilla E, Raventós C, Cecchini L, Orsola A, Salvador C, Placer J, Encabo G, Morote J.
    BJU Int; 2009 Dec 25; 104(11):1637-40. PubMed ID: 19549260
    [Abstract] [Full Text] [Related]

  • 38. Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers.
    Hamel ME, Sebaldt RJ, Siminoski K, Adachi JD, Papadimitropoulos E, Petrie A, Goldsmith CH.
    Osteoporos Int; 2005 Feb 25; 16(2):208-15. PubMed ID: 15517185
    [Abstract] [Full Text] [Related]

  • 39. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF, Passadakis SP, Tam P, Memmos ED, Katopodis PK, Ozener C, Akçiçek F, Camsari T, Ateş K, Ataman R, Vlachojannis JG, Dombros AN, Utaş C, Akpolat T, Bozfakioğlu S, Wu G, Karayaylali I, Arinsoy T, Stathakis PC, Yavuz M, Tsakiris JD, Dimitriades CA, Yilmaz ME, Gültekin M, Karayalçin B, Yardimsever M, Oreopoulos DG.
    J Bone Miner Metab; 2006 Feb 25; 24(1):79-86. PubMed ID: 16369903
    [Abstract] [Full Text] [Related]

  • 40. Predictive and modifying factors of bone mineral density decline in patients with COPD.
    Kameyama N, Chubachi S, Sasaki M, Tsutsumi A, Irie H, Sakurai K, Sayama K, Nakamura H, Asano K, Betsuyaku T, Fukunaga K.
    Respir Med; 2019 Mar 25; 148():13-23. PubMed ID: 30827469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.